Approval · Notice of Compliance 16797 · 2015
VOLULYTE: Notice of Compliance 16797
Issued April 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16797
- Date
- April 14, 2015
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Plaaasma volume expander
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLULYTE | 02357291 | Marketed |
Medicinal ingredients
- HYDROXYETHYL STARCH 6 PER